• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

社会剥夺状况对动脉粥样硬化性心血管疾病队列风险方程的表现影响。

Performance of the Atherosclerotic Cardiovascular Disease Pooled Cohort Risk Equations by Social Deprivation Status.

机构信息

Department of Epidemiology, School of Public Health, University of Alabama at Birmingham, AL

Department of Surgery, School of Medicine, University of Alabama at Birmingham, AL.

出版信息

J Am Heart Assoc. 2017 Mar 17;6(3):e005676. doi: 10.1161/JAHA.117.005676.

DOI:10.1161/JAHA.117.005676
PMID:28314800
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC5524046/
Abstract

BACKGROUND

The atherosclerosis cardiovascular disease (ASCVD) Pooled Cohort risk equations have shown different calibration across US populations with varied levels of social deprivation.

METHODS AND RESULTS

We analyzed the calibration and discrimination of the Pooled Cohort risk equations by social deprivation status among 9066 REGARDS (REasons for Geographic And Racial Differences in Stroke) study participants not taking statins for whom ASCVD risk may lead to statin initiation. Patients were aged 45 to 79 years, had no ASCVD or diabetes mellitus, and had a low-density lipoprotein cholesterol level 70 to 189 mg/dL. Social deprivation was defined using 3 indicators: annual household income <$25 000, less than a high school education, and living without a partner. At baseline in 2003-2007, 54.6%, 27.4%, and 18.0% of participants had 0, 1, and 2 or 3 indicators showing deprivation, respectively. From baseline through December 2012, 457 participants developed ASCVD (nonfatal/fatal stroke, myocardial infarction, or coronary heart disease death). Predicted and observed ASCVD incidence per 1000 person-years were 8.02 and 6.23 (95% CI, 5.31-7.31), respectively, among participants with 0 indicators of deprivation (Hosmer-Lemeshow =0.01); 8.05 and 6.61 (95% CI, 5.29-8.24), respectively, with 1 indicator (=0.09); and 9.83 and 11.40 (95% CI, 9.23-14.05), respectively, with 2 or 3 indicators (=0.12). The C-index (95% CI) was 0.72 (0.69-0.75), 0.73 (0.69-0.78), and 0.70 (0.65-0.75) among participants with 0, 1, and 2 or 3 indicators of deprivation, respectively. The net reclassification improvement after adding deprivation data to the Pooled Cohort risk equations was modest (0.12; 95% CI, 0.03-0.21).

CONCLUSIONS

The Pooled Cohort risk equations have good calibration among individuals with social deprivation but overestimate ASCVD risk among those with less social deprivation.

摘要

背景

动脉粥样硬化性心血管疾病(ASCVD)的汇总队列风险方程在社会剥夺程度不同的美国人群中表现出不同的校准。

方法和结果

我们在 9066 名 REGARDS(地理和种族差异中风原因)研究参与者中分析了汇总队列风险方程按社会剥夺状态的校准和区分,这些参与者未服用他汀类药物,ASCVD 风险可能导致开始使用他汀类药物。患者年龄在 45 至 79 岁之间,无 ASCVD 或糖尿病,且低密度脂蛋白胆固醇水平为 70 至 189mg/dL。社会剥夺程度使用 3 个指标定义:家庭年收入<25000 美元、未接受过高中教育以及没有伴侣。在 2003-2007 年的基线时,分别有 54.6%、27.4%和 18.0%的参与者有 0、1 和 2 或 3 个显示剥夺的指标。截至 2012 年 12 月,有 457 名参与者发生 ASCVD(非致命/致命性中风、心肌梗死或冠心病死亡)。无剥夺指标的参与者每 1000 人年的预测和观察到的 ASCVD 发生率分别为 8.02 和 6.23(95%CI,5.31-7.31)(Hosmer-Lemeshow=0.01);分别有 1 个指标的发生率分别为 8.05 和 6.61(95%CI,5.29-8.24)(Hosmer-Lemeshow=0.09);有 2 或 3 个指标的发生率分别为 9.83 和 11.40(95%CI,9.23-14.05)(Hosmer-Lemeshow=0.12)。无剥夺指标的参与者的 C 指数(95%CI)分别为 0.72(0.69-0.75)、0.73(0.69-0.78)和 0.70(0.65-0.75)。在有 0、1 和 2 或 3 个社会剥夺指标的参与者中,分别为 0.12(95%CI,0.03-0.21)。

结论

汇总队列风险方程在社会弱势群体中具有良好的校准性,但在社会弱势群体中高估了 ASCVD 风险。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/aa54/5524046/81bac89b0c04/JAH3-6-e005676-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/aa54/5524046/81bac89b0c04/JAH3-6-e005676-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/aa54/5524046/81bac89b0c04/JAH3-6-e005676-g001.jpg

相似文献

1
Performance of the Atherosclerotic Cardiovascular Disease Pooled Cohort Risk Equations by Social Deprivation Status.社会剥夺状况对动脉粥样硬化性心血管疾病队列风险方程的表现影响。
J Am Heart Assoc. 2017 Mar 17;6(3):e005676. doi: 10.1161/JAHA.117.005676.
2
Risk Prediction for Atherosclerotic Cardiovascular Disease With and Without Race Stratification.有无种族分层情况下动脉粥样硬化性心血管疾病的风险预测
JAMA Cardiol. 2024 Jan 1;9(1):55-62. doi: 10.1001/jamacardio.2023.4520.
3
Risk-enhancing factors and social determinants of health in risk assessment for atherosclerotic cardiovascular disease.动脉粥样硬化性心血管疾病风险评估中的风险增强因素和健康的社会决定因素。
PLoS One. 2024 Oct 25;19(10):e0312756. doi: 10.1371/journal.pone.0312756. eCollection 2024.
4
Independence of Lipoprotein(a) and Low-Density Lipoprotein Cholesterol-Mediated Cardiovascular Risk: A Participant-Level Meta-Analysis.脂蛋白(a)与低密度脂蛋白胆固醇介导的心血管风险的独立性:一项基于参与者水平的荟萃分析。
Circulation. 2025 Jan 28;151(4):312-321. doi: 10.1161/CIRCULATIONAHA.124.069556. Epub 2024 Nov 4.
5
Evaluation and Comparison of the PREVENT and Pooled Cohort Equations for 10-Year Atherosclerotic Cardiovascular Risk Prediction.用于预测10年动脉粥样硬化性心血管风险的PREVENT方程与合并队列方程的评估及比较
J Am Heart Assoc. 2025 Feb 18;14(4):e039454. doi: 10.1161/JAHA.124.039454. Epub 2025 Feb 8.
6
Aspirin Dosing for Secondary Prevention of Atherosclerotic Cardiovascular Disease in Male and Female Patients: A Secondary Analysis of the ADAPTABLE Randomized Clinical Trial.阿司匹林在男性和女性动脉粥样硬化性心血管疾病二级预防中的剂量:ADAPTABLE 随机临床试验的二次分析。
JAMA Cardiol. 2024 Sep 1;9(9):808-816. doi: 10.1001/jamacardio.2024.1712.
7
Performance of the pooled cohort equations and D:A:D risk scores among individuals with HIV in a global cardiovascular disease prevention trial: a cohort study leveraging data from REPRIEVE.在一项全球心血管疾病预防试验中,对感染艾滋病毒个体应用汇总队列方程和D:A:D风险评分的情况:一项利用REPRIEVE研究数据的队列研究
Lancet HIV. 2025 Feb;12(2):e118-e129. doi: 10.1016/S2352-3018(24)00276-5. Epub 2025 Jan 17.
8
Low-Density Lipoprotein Cholesterol Lowering for the Primary Prevention of Cardiovascular Disease Among Men With Primary Elevations of Low-Density Lipoprotein Cholesterol Levels of 190 mg/dL or Above: Analyses From the WOSCOPS (West of Scotland Coronary Prevention Study) 5-Year Randomized Trial and 20-Year Observational Follow-Up.男性原发性低密度脂蛋白胆固醇水平升高至 190mg/dL 或以上的心血管疾病一级预防中降低低密度脂蛋白胆固醇:来自 WOSCOPS(苏格兰西部冠状动脉预防研究)5 年随机试验和 20 年观察随访的分析。
Circulation. 2017 Nov 14;136(20):1878-1891. doi: 10.1161/CIRCULATIONAHA.117.027966. Epub 2017 Sep 6.
9
Mobile phone text messaging for medication adherence in secondary prevention of cardiovascular disease.手机短信用于心血管疾病二级预防中的药物依从性。
Cochrane Database Syst Rev. 2024 Mar 27;3(3):CD011851. doi: 10.1002/14651858.CD011851.pub3.
10
Statins for the primary prevention of cardiovascular disease.他汀类药物用于心血管疾病的一级预防。
Cochrane Database Syst Rev. 2013 Jan 31;2013(1):CD004816. doi: 10.1002/14651858.CD004816.pub5.

引用本文的文献

1
PREVENT and PCE Models for Estimating ASCVD Risk Stratified by Statin Exposure.用于估计按他汀类药物暴露分层的动脉粥样硬化性心血管疾病(ASCVD)风险的PREVENT和PCE模型。
JAMA Netw Open. 2025 Sep 2;8(9):e2532164. doi: 10.1001/jamanetworkopen.2025.32164.
2
Atherosclerotic Cardiovascular Disease Risk Estimates Using the New Predicting Risk of Cardiovascular Disease Events Equations: Implications for Statin Use.使用新的心血管疾病事件风险预测方程评估动脉粥样硬化性心血管疾病风险:对他汀类药物使用的影响
Curr Cardiol Rep. 2025 Jul 2;27(1):107. doi: 10.1007/s11886-025-02244-5.
3
Performance of PREVENT and pooled cohort equations for predicting 10-Year ASCVD risk in the UK Biobank.

本文引用的文献

1
Calibration of the Pooled Cohort Equations for Atherosclerotic Cardiovascular Disease: An Update.动脉粥样硬化性心血管疾病 pooled 队列方程的校准:更新。
Ann Intern Med. 2016 Dec 6;165(11):786-794. doi: 10.7326/M16-1739. Epub 2016 Oct 11.
2
The Pooled Cohort Equations for Predicting Risk of Myocardial Infarction and Stroke: Validated in Representative Natural History Populations.
Mayo Clin Proc. 2016 Jun;91(6):692-4. doi: 10.1016/j.mayocp.2016.04.027. Epub 2016 May 11.
3
The Critical Importance of Risk Score Calibration: Time for Transformative Approach to Risk Score Validation?风险评分校准的至关重要性:是时候采用变革性方法进行风险评分验证了吗?
PREVENT及汇总队列方程在英国生物银行中预测10年动脉粥样硬化性心血管疾病(ASCVD)风险的性能。
Am J Prev Cardiol. 2025 May 18;22:101009. doi: 10.1016/j.ajpc.2025.101009. eCollection 2025 Jun.
4
Development and validation of nomograms including individual- and area-level variables to predict risk of fatal and non-fatal cardiovascular diseases among Russian population.包含个体和地区层面变量的列线图的开发与验证,用于预测俄罗斯人群中致命和非致命心血管疾病的风险。
PLoS One. 2025 Jun 2;20(5):e0324736. doi: 10.1371/journal.pone.0324736. eCollection 2025.
5
Food Insecurity and Incident Cardiovascular Disease Among Black and White US Individuals, 2000-2020.2000 - 2020年美国黑人和白人中的粮食不安全与心血管疾病发病情况
JAMA Cardiol. 2025 May 1;10(5):456-462. doi: 10.1001/jamacardio.2025.0109.
6
Evaluation and Comparison of the PREVENT and Pooled Cohort Equations for 10-Year Atherosclerotic Cardiovascular Risk Prediction.用于预测10年动脉粥样硬化性心血管风险的PREVENT方程与合并队列方程的评估及比较
J Am Heart Assoc. 2025 Feb 18;14(4):e039454. doi: 10.1161/JAHA.124.039454. Epub 2025 Feb 8.
7
2025 Heart Disease and Stroke Statistics: A Report of US and Global Data From the American Heart Association.《2025年心脏病和中风统计数据:美国心脏协会关于美国和全球数据的报告》
Circulation. 2025 Feb 25;151(8):e41-e660. doi: 10.1161/CIR.0000000000001303. Epub 2025 Jan 27.
8
Atherosclerotic Cardiovascular Disease Risk Scores are Associated with Carotid Intima-Media Thickness.动脉粥样硬化性心血管疾病风险评分与颈动脉内膜中层厚度相关。
Clin Nurs Res. 2025 May;34(3-4):160-167. doi: 10.1177/10547738241305784. Epub 2025 Jan 4.
9
Space for improvement: ZIP codes should not determine cardiovascular longevity, a scoping review.有待改进之处:邮政编码不应决定心血管疾病的寿命,一项范围综述。
Trends Cardiovasc Med. 2025 May;35(4):214-218. doi: 10.1016/j.tcm.2024.12.005. Epub 2024 Dec 10.
10
Risk-enhancing factors and social determinants of health in risk assessment for atherosclerotic cardiovascular disease.动脉粥样硬化性心血管疾病风险评估中的风险增强因素和健康的社会决定因素。
PLoS One. 2024 Oct 25;19(10):e0312756. doi: 10.1371/journal.pone.0312756. eCollection 2024.
J Am Coll Cardiol. 2016 May 10;67(18):2131-2134. doi: 10.1016/j.jacc.2016.03.479.
4
Social Determinants of Risk and Outcomes for Cardiovascular Disease: A Scientific Statement From the American Heart Association.心血管疾病风险与预后的社会决定因素:美国心脏协会科学声明
Circulation. 2015 Sep 1;132(9):873-98. doi: 10.1161/CIR.0000000000000228. Epub 2015 Aug 3.
5
Impact of Socioeconomic Status on Cardiovascular Disease and Mortality in 24,947 Individuals With Type 1 Diabetes.24947 例 1 型糖尿病患者社会经济地位对心血管疾病和死亡率的影响。
Diabetes Care. 2015 Aug;38(8):1518-27. doi: 10.2337/dc15-0145. Epub 2015 May 13.
6
An analysis of calibration and discrimination among multiple cardiovascular risk scores in a modern multiethnic cohort.现代多民族队列中多种心血管风险评分的校准与鉴别分析。
Ann Intern Med. 2015 Feb 17;162(4):266-75. doi: 10.7326/M14-1281.
7
Neighborhood socioeconomic disadvantage and 30-day rehospitalization: a retrospective cohort study.社区社会经济劣势与30天再入院率:一项回顾性队列研究。
Ann Intern Med. 2014 Dec 2;161(11):765-74. doi: 10.7326/M13-2946.
8
Further insight into the cardiovascular risk calculator: the roles of statins, revascularizations, and underascertainment in the Women's Health Study.进一步深入了解心血管风险计算器:他汀类药物、血运重建术和妇女健康研究中的信息不足在其中所扮演的角色。
JAMA Intern Med. 2014 Dec;174(12):1964-71. doi: 10.1001/jamainternmed.2014.5336.
9
Statin underuse and low prevalence of LDL-C control among U.S. adults at high risk of coronary heart disease.美国高冠心病风险的成年人他汀类药物使用率低且 LDL-C 控制率低。
Am J Med Sci. 2014 Aug;348(2):108-14. doi: 10.1097/MAJ.0000000000000292.
10
The contribution of educational class in improving accuracy of cardiovascular risk prediction across European regions: The MORGAM Project Cohort Component.教育阶层对提高欧洲各地区心血管疾病风险预测准确性的贡献:MORGAM项目队列组成部分
Heart. 2014 Aug;100(15):1179-87. doi: 10.1136/heartjnl-2013-304664. Epub 2014 May 1.